• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受阿片类药物治疗的澳大利亚慢性非癌性疼痛成年患者在医疗服务利用和感知到的就医障碍方面的地理差异。

Geographic Variation in Health Service Use and Perceived Access Barriers for Australian Adults with Chronic Non-Cancer Pain Receiving Opioid Therapy.

作者信息

Peacock Amy, Nielsen Suzanne, Bruno Raimondo, Campbell Gabrielle, Larance Briony, Degenhardt Louisa

机构信息

School of Medicine (Psychology), University of Tasmania, Hobart, Tasmania, Australia

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia.

出版信息

Pain Med. 2016 Nov;17(11):2003-2016. doi: 10.1093/pm/pnw109. Epub 2016 Jun 10.

DOI:10.1093/pm/pnw109
PMID:27288946
Abstract

OBJECTIVE

Rates of chronic non-cancer pain are increasing worldwide, with concerns regarding poorer access to specialist treatment services in remote areas. The current study comprised the first in-depth examination of use and barriers to access of health services in Australia according to remoteness.

METHODS

A cohort of Australian adults prescribed pharmaceutical opioids for chronic non-cancer pain (n = 1,235) were interviewed between August 2012 and April 2014, and grouped into 'major city' (49%), 'inner regional' (37%), and 'outer regional/remote' (14%) according to the Australian Standard Geographical Classification based on postcode. Multinomial logistic regression analyses were conducted to determine geographical differences in socio-demographic and clinical characteristics, health service use, and perceived barriers to health service access.

RESULTS

The 'inner regional group' and 'outer regional/remote group' were more likely to be male (relative risk ratio (RRR)=1.38,95%CI 1.08-1.77 and RRR = 1.60, 95%CI 1.14-2.24) and have no private health insurance (RRR = 1.53, 95%CI 1.19-1.97 and RRR = 1.65, 95%CI 1.16-2.37) than the 'major city group' (49%). However, the 'inner regional group' reported lower pain severity and better mental health relative to the 'major city group' = 0.92, 95%CI 0.86-0.98 and RRR = 1.02, 95%CI 1.01-1.03, respectively). Although rates of health service access were generally similar, the 'outer regional/remote group' were more likely to report client-practitioner communication problems (RRR = 1.57, 95%CI 1.03-2.37), difficulties accessing specialists (RRR = 1.56, 95%CI 1.01-2.39), and perception of practitioner lack of confidence in prescribing pain medication (RRR = 1.73, 1.14-2.62), relative to both groups.

CONCLUSION

Perceived communication, access, and financial barriers to healthcare indicate the need for increased efforts to address geographic inequality in pain treatment.

摘要

目的

慢性非癌性疼痛的发病率在全球范围内呈上升趋势,人们担心偏远地区获得专科治疗服务的机会较少。本研究首次对澳大利亚不同偏远程度地区卫生服务的使用情况和获取障碍进行了深入调查。

方法

2012年8月至2014年4月间,对一组因慢性非癌性疼痛而开具了阿片类药物处方的澳大利亚成年人(n = 1235)进行了访谈,并根据基于邮政编码的澳大利亚标准地理分类,将他们分为“大城市”组(49%)、“内地区域”组(37%)和“外地区域/偏远”组(14%)。进行多项逻辑回归分析,以确定社会人口统计学和临床特征、卫生服务使用情况以及卫生服务获取方面的感知障碍的地理差异。

结果

与“大城市”组(49%)相比,“内地区域”组和“外地区域/偏远”组男性比例更高(相对风险比(RRR)= 1.38,95%置信区间1.08 - 1.77和RRR = 1.60,95%置信区间1.14 - 2.24),且没有私人医疗保险的比例更高(RRR = 1.53,95%置信区间1.19 - 1.97和RRR = 1.65,95%置信区间1.16 - 2.37)。然而,与“大城市”组相比,“内地区域”组报告的疼痛严重程度较低,心理健康状况较好(分别为RRR = 0.92,95%置信区间0.86 - 0.98和RRR = 1.02,95%置信区间1.01 - 1.03)。尽管卫生服务获取率总体相似,但与其他两组相比,“外地区域/偏远”组更有可能报告医患沟通问题(RRR = 1.57,95%置信区间1.03 - 2.37)、看专科医生困难(RRR = 1.56,95%置信区间1.01 - 2.39)以及认为医生对开具止痛药缺乏信心(RRR = 1.73,1.14 - 2.62)。

结论

对医疗保健的沟通、获取和经济障碍的感知表明,需要加大力度解决疼痛治疗中的地理不平等问题。

相似文献

1
Geographic Variation in Health Service Use and Perceived Access Barriers for Australian Adults with Chronic Non-Cancer Pain Receiving Opioid Therapy.接受阿片类药物治疗的澳大利亚慢性非癌性疼痛成年患者在医疗服务利用和感知到的就医障碍方面的地理差异。
Pain Med. 2016 Nov;17(11):2003-2016. doi: 10.1093/pm/pnw109. Epub 2016 Jun 10.
2
Health service utilisation by people living with chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study.慢性非癌性疼痛患者的医疗服务利用情况:疼痛与阿片类药物治疗(POINT)研究的结果
Aust Health Rev. 2016 Nov;40(5):490-499. doi: 10.1071/AH15047.
3
Do transdermal opioids affect the personal socioeconomic costs of healthcare access in an australian rural pain population? A comparison with oral opioids.
J Opioid Manag. 2012 Mar-Apr;8(2):126-32. doi: 10.5055/jom.2012.0105.
4
Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.慢性非癌痛患者使用大麻对阿片类药物处方的影响:一项为期 4 年的前瞻性队列研究结果。
Lancet Public Health. 2018 Jul;3(7):e341-e350. doi: 10.1016/S2468-2667(18)30110-5.
5
Determinants of access to eHealth services in regional Australia.澳大利亚区域内获得电子健康服务的决定因素。
Int J Med Inform. 2019 Nov;131:103960. doi: 10.1016/j.ijmedinf.2019.103960. Epub 2019 Sep 4.
6
Opioid therapy in the treatment of chronic pain conditions in Germany.德国慢性疼痛疾病治疗中的阿片类药物疗法
Pain Physician. 2015 May-Jun;18(3):E323-31.
7
Analysing risk factors for poorer breast cancer outcomes in residents of lower socioeconomic areas of Australia.分析澳大利亚社会经济较低地区居民乳腺癌预后较差的风险因素。
Aust Health Rev. 2014 May;38(2):134-41. doi: 10.1071/AH13080.
8
The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids.在开具阿片类药物的慢性非癌性疼痛人群社区样本中对乙酰氨基酚(扑热息痛)的使用情况。
Int J Clin Pract. 2015 Nov;69(11):1366-76. doi: 10.1111/ijcp.12716. Epub 2015 Aug 13.
9
Trajectories of prescription opioid tapering in patients with chronic non-cancer pain: a retrospective cohort study, 2015-2020.2015-2020 年慢性非癌痛患者阿片类药物递减治疗轨迹:回顾性队列研究。
Pain Med. 2024 Apr 3;25(4):263-274. doi: 10.1093/pm/pnae002.
10
Discrepancies Between Perceived Benefit of Opioids and Self-Reported Patient Outcomes.患者对阿片类药物疗效的感知与自我报告的患者结局存在差异。
Pain Med. 2018 Feb 1;19(2):297-306. doi: 10.1093/pm/pnw263.

引用本文的文献

1
Utilization of telemedicine in conjunction with wearable devices for patients with chronic musculoskeletal pain: a randomized controlled clinical trial.远程医疗结合可穿戴设备用于慢性肌肉骨骼疼痛患者:一项随机对照临床试验。
Sci Rep. 2025 Jan 9;15(1):1396. doi: 10.1038/s41598-024-85056-x.
2
Predictors of persistent opioid use in Australian primary care: A retrospective cohort study, 2018-2022.澳大利亚初级医疗中持续使用阿片类药物的预测因素:一项2018 - 2022年的回顾性队列研究
Pain Med. 2024 Aug 6;25(12):748-57. doi: 10.1093/pm/pnae071.
3
COVID-19 restrictions and the incidence and prevalence of prescription opioid use in Australia - a nationwide study.
澳大利亚的 COVID-19 限制措施与处方类阿片使用的发病率和流行率:一项全国性研究。
Br J Clin Pharmacol. 2023 Feb;89(2):914-920. doi: 10.1111/bcp.15577. Epub 2022 Nov 25.
4
The relationship between patients' income and education and their access to pharmacological chronic pain management: A scoping review.患者的收入和教育水平与其获得慢性疼痛药物治疗的关系:一项范围综述。
Can J Pain. 2022 Sep 1;6(1):142-170. doi: 10.1080/24740527.2022.2104699. eCollection 2022.
5
Geospatial Analyses of Pain Intensity and Opioid Unit Doses Prescribed on the Day of Discharge Following Orthopedic Surgery.骨科手术后出院当天疼痛强度和阿片类药物单位剂量的地理空间分析。
Pain Med. 2020 Aug 1;21(8):1644-1662. doi: 10.1093/pm/pnz311.
6
Optimizing cancer pain management in resource-limited settings.优化资源有限环境下的癌症疼痛管理。
Support Care Cancer. 2019 Jun;27(6):2113-2124. doi: 10.1007/s00520-018-4471-z. Epub 2018 Sep 21.